MAPP: Imagery-focused Therapy for Bipolar Disorder
MAPP
Mood Action Psychology Programme (MAPP): a Case Series Investigation of Brief Imagery-focused Cognitive Therapy (imCT) for Bipolar Disorder.
1 other identifier
interventional
15
1 country
4
Brief Summary
Bipolar Disorder (BD) (previously known as "manic depression") is a severe mental health illness affecting at least 1% of the population and with annual NHS cost estimated at £342 million. It is characterised by alternating episodes of acute mood swings: depression and "mania" (mood elation). BD also comes with less severe mood swings we call "mood instability", and ongoing high levels of anxiety that impair well-being even during periods between the acute mood breakdowns. Anxiety and mood instability are associated with worse outcome of the disorder. All these symptoms can be accompanied by the presence of troublesome mental images (e.g. seeing a memory in the mind's eye) such as intrusive "flashbacks" of negative past events. Recent studies suggest that individuals with BD experience more vivid, compelling and upsetting mental images compared to other patient groups and this could contribute to their clinical difficulties. Cognitive Behavioural Therapy (CBT) is a well established and successful psychological therapy used in the National Health Service (NHS), UK but as yet with limited efficacy in BD. Targeting mental imagery has long been part of general CBT. In particular, imagery-based treatment techniques have proved successful in anxiety disorders, but have not been brought to CBT for Bipolar Disorder yet. Our study Mood Action Psychology Programme (MAPP) investigates the delivery of a brief imagery-focused cognitive therapy (imCT) intervention to people with BD, studying a series of patients in detail one by one a "case series"). We offer a structured and individualised psychological treatment in line with the aims of NHS guidelines. The imCT protocol has been successfully delivered and audited in our psychological service in Oxford (OxMAPP). The proposed MAPP study aims to formally assess for the first time the effectiveness of imCT. In particular we hypothesise that imCT via the Mood Action Psychology Programme (MAPP) will result in (i) reduced levels of anxiety and (ii) reduced levels of low mood after treatment compared to baseline (both measured over 4 weeks) in individuals with BD. Overall, this works aims to contribute to improved psychological treatment for BD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2013
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2013
CompletedFirst Submitted
Initial submission to the registry
November 5, 2013
CompletedFirst Posted
Study publicly available on registry
November 11, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2015
CompletedSeptember 30, 2015
September 1, 2015
1.7 years
November 5, 2013
September 29, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Anxiety and depression scores change
To assess the primary endpoint in the study, i.e the change in scores on measures of (i) Beck Anxiety Inventory (BAI) (Beck \& Steer, 1993) (ii) Quick Inventory of Depressive Symptoms (QIDS) (Rush et al., 2003) after treatment, pooled scores from aggregated time points over 4 weeks after treatment compared to aggregated time points over baseline changes anxiety (BAI) and low mood (QIDS) are used. This method is advised given that traditional self-report mood ratings over a single time point are scarcely representative of mood variability in BD. For this scope the following assessments are repeated weekly for all study duration: * Quick Inventory of Depressive Symptomatology, Self-Report (QIDS) (Rush et al., 2003) * Beck Anxiety Inventory (BAI) (Beck \& Steer, 1993)
4 weeks
Secondary Outcomes (8)
Changes in Imagery Characteristics
4 weeks
Anxiety and depression change maintenance at follow up
12 and 24 weeks
Mood instability
4 weeks and 24 weeks
Depression and mania relapse rate and duration
24 weeks
Anxiety comorbidity
24 weeks
- +3 more secondary outcomes
Study Arms (1)
Imagery-focused Cognitive Therapy
EXPERIMENTAL10 sessions of imagery-focused Cognitive Therapy delivered approximately weekly by two co-therapists, divided in 4 assessment, 4 treatment and 4 consolidation sessions; additional 2 "blip" management sessions during therapy and 3 "blip" management and booster session during follow up can be delivered if necessary.
Interventions
ImCT Therapy is carried out by a team of 2 co-therapists and comprises of: * Mapping: Therapists and patient collaboratively map out difficulties and pinpoint a treatment focus, with regards to imagery symptoms and anxiety co-morbidity that impact on bipolar mood instability. This leads to an individualised formulation of the patient's current problem. * Target: Follows the rationale, timing and objectives identified collaboratively in Mapping. It is structured around imagery-based techniques, such as imagery rescripting, which are used to address problematic imagery, to promote management of mood and boost self-care. This results into the acquisition of imagery-based mood- and anxiety-regulating strategies to be integrated into the patient's already existing coping strategies. * Consolidation: Consist of fine tuning the strategies devised during Target based on experience gained after testing them out in real life situations and includes a "video blue print.
Eligibility Criteria
You may qualify if:
- Male or Female, aged 18 - 65 years old
- Have adequate English language ability to permit the assessment and experimental measures to be completed
- Have diagnosis of Bipolar Disorder (I or II or NOS) according to Diagnostic and Statistical Manual IV-TR (DSM-IV) criteria (American Psychiatric Association, 2000) as indicated by the Structured Clinical Interview for DSM-IV (SCID) (First, Spitzer, M., \& Williams, 2002)
- Are willing to complete daily/weekly mood and anxiety monitoring throughout the duration of the study
- Successfully complete daily monitoring in the 4 weeks active run-in phase
- Are willing to have regular treatment reports and letters sent to their GP and other relevant clinicians
- Can commit to attending 10 consecutive weekly sessions, including questionnaires completion, and follow up period as required by the study
- Are residents within geographical areas covered by the NHS trusts where treatment is delivered
You may not qualify if:
- Do not have diagnosis of Bipolar Disorder (I or II or NOS) according to Diagnostic and Statistical Manual IV-TR (DSM-IV) (American Psychiatric Association, 2000) criteria as indicated by the Structured Clinical Interview for DSM-IV (First et al., 2002)
- Learning difficulties, organic brain disease, severe neurological impairment
- Current severe substance or alcohol misuse (clinicians assessment)
- Current manic episode as diagnosed by DSM-IV criteria (American Psychiatric Association, 2000) indicated by the SCID (First et al., 2002)
- Current active psychotic symptoms
- Presence of active suicidal risk as indicated by a score of 2 or more on item 12 of the QIDS (Rush et al., 2003) (i.e. frequent thoughts and/or plans to end their life) confirmed by convergent clinical opinion
- Unwilling to engage actively in treatment or to use an imagery-focussed approach for treatment
- Taking part in concurrent treatment studies investigating pharmacological or psychological treatment for BD
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Medical Research Council Cognition and Brain Sciences Unitlead
- Cambridgeshire and Peterborough NHS Foundation Trustcollaborator
- Oxford Health NHS Foundation Trustcollaborator
- University of Cambridgecollaborator
- University of Oxfordcollaborator
Study Sites (4)
MRC Cognition and Brain Sciences Unit
Cambridge, CB2 7EF, United Kingdom
Cambridge and Peterborough NHS Foundation Trust
Cambridge, United Kingdom
University of Oxford, Department of Psychiatry
Oxford, Ox3 7JX, United Kingdom
Oxford Health NHS Foundation Trust
Oxford, United Kingdom
Related Publications (4)
Holmes EA, Deeprose C, Fairburn CG, Wallace-Hadrill SM, Bonsall MB, Geddes JR, Goodwin GM. Mood stability versus mood instability in bipolar disorder: a possible role for emotional mental imagery. Behav Res Ther. 2011 Oct;49(10):707-13. doi: 10.1016/j.brat.2011.06.008. Epub 2011 Jul 5.
PMID: 21798515BACKGROUNDBonsall MB, Wallace-Hadrill SM, Geddes JR, Goodwin GM, Holmes EA. Nonlinear time-series approaches in characterizing mood stability and mood instability in bipolar disorder. Proc Biol Sci. 2012 Mar 7;279(1730):916-24. doi: 10.1098/rspb.2011.1246. Epub 2011 Aug 17.
PMID: 21849316BACKGROUNDHolmes EA, Geddes JR, Colom F, Goodwin GM. Mental imagery as an emotional amplifier: application to bipolar disorder. Behav Res Ther. 2008 Dec;46(12):1251-8. doi: 10.1016/j.brat.2008.09.005. Epub 2008 Oct 8.
PMID: 18990364BACKGROUNDHolmes EA, Bonsall MB, Hales SA, Mitchell H, Renner F, Blackwell SE, Watson P, Goodwin GM, Di Simplicio M. Applications of time-series analysis to mood fluctuations in bipolar disorder to promote treatment innovation: a case series. Transl Psychiatry. 2016 Jan 26;6(1):e720. doi: 10.1038/tp.2015.207.
PMID: 26812041DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Emily A Holmes, PhD
Medical Research Council Cognition and Brain Sciences Unit
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 5, 2013
First Posted
November 11, 2013
Study Start
November 1, 2013
Primary Completion
July 1, 2015
Study Completion
July 1, 2015
Last Updated
September 30, 2015
Record last verified: 2015-09